marketcaparena
Search

    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Company overview

    Market capitalization
    $286.51M
    Employees
    202
    Latest publication
    2026-09-29
    About ROCKET PHARMACEUTICALS, INC.

    Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), which is in phase 1; and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is a form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart, which is in preclinical stage. It also develops ex vivo lentiviral (LV) programs, which include programs for Leukocyte Adhesion Deficiency-I (LAD-I), a genetic disorder that causes the immune system to malfunction (RP-L201); Fanconi Anemia (FA), a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells (RP-L102); and Pyruvate Kinase Deficiency (PKD), a red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia (RP-L301). It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red de Enfermedades Raras, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and Temple University. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Total Revenue0USD0USD0USD0USD0USD9,186,000USD0USD0USD
    Cost Of Revenue2,146,000USD——2,539,000USD2,989,000USD—2,339,000USD2,254,000USD
    Gross Profit-2,146,000USD——-2,539,000USD-2,989,000USD4,593,000USD-2,339,000USD-2,254,000USD
    Research Development31,454,000USD29,347,000USD34,068,000USD42,658,000USD35,942,000USD37,357,000USD44,792,000USD43,760,000USD
    Selling General Administrative17,057,000USD14,684,000USD18,351,000USD25,020,000USD28,446,000USD25,337,000USD27,367,000USD22,148,000USD
    Unclassified Operating Expenses-2,146,000USD——3,471,000USD————
    Total Operating Expenses46,365,000USD43,963,000USD52,247,000USD71,149,000USD64,388,000USD62,694,000USD71,373,000USD65,121,000USD
    Operating Income-48,511,000USD-43,963,000USD-52,247,000USD-71,149,000USD-64,388,000USD-62,694,000USD-73,712,000USD-67,375,000USD
    Interest Income1,390,000USD1,898,000USD2,388,000USD2,703,000USD3,526,000USD2,840,000USD4,537,000USD5,792,000USD
    Interest Expense473,000USD3,309,000USD473,000USD473,000USD472,000USD473,000USD471,000USD471,000USD
    Net Interest Income917,000USD1,425,000USD1,915,000USD2,230,000USD3,054,000USD2,367,000USD4,066,000USD5,321,000USD
    Income Before Tax-47,594,000USD-42,538,000USD-50,332,000USD-68,919,000USD-61,334,000USD-60,327,000USD-69,646,000USD-62,054,000USD
    Net Income-47,594,000USD-42,538,000USD-50,332,000USD-68,919,000USD-61,334,000USD-60,327,000USD-69,646,000USD-62,054,000USD
    Net Income From Continuing Ops-47,594,000USD-42,538,000USD-50,332,000USD-68,919,000USD-61,334,000USD-60,327,000USD-69,646,000USD-62,054,000USD
    Ebit-47,121,000USD-39,229,000USD-49,859,000USD-68,446,000USD-60,862,000USD-59,854,000USD-69,175,000USD-61,583,000USD
    Ebitda-44,975,000USD-37,012,000USD-46,619,000USD-65,867,000USD-57,873,000USD-57,493,000USD-66,836,000USD-59,329,000USD
    Depreciation And Amortization2,146,000USD2,217,000USD3,240,000USD2,579,000USD2,989,000USD2,361,000USD2,339,000USD2,254,000USD
    Reconciled Depreciation2,146,000USD2,217,000USD3,240,000USD2,579,000USD2,989,000USD2,361,000USD2,371,000USD2,254,000USD
    Total Other Income Expense Net917,000USD1,425,000USD1,915,000USD2,230,000USD3,054,000USD2,367,000USD4,066,000USD5,321,000USD
    Income Tax Expense———————1USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20142014-12-31 · USD
    Total Revenue0USD0USD0USD0USD0USD0USD0USD0USD
    Cost Of Revenue11,025,000USD9,375,000USD5,373,000USD1,145,000USD426,000USD204,000USD169,000USD0USD
    Gross Profit-11,025,000USD-9,375,000USD-5,373,000USD-1,145,000USD-426,000USD-204,000USD-169,000USD0USD
    Research Development142,015,000USD171,244,000USD125,476,000USD106,382,000USD58,623,000USD14,193,000USD31,985,000USD5,592,000USD
    Selling General Administrative86,501,000USD101,961,000USD41,772,000USD27,921,000USD17,528,000USD12,544,000USD9,894,000USD2,112,000USD
    Unclassified Operating Expenses-11,025,000USD———————
    Total Operating Expenses217,491,000USD273,205,000USD167,248,000USD134,858,000USD75,901,000USD26,737,000USD41,879,000USD7,704,000USD
    Operating Income-228,516,000USD-273,205,000USD-167,248,000USD-136,003,000USD-76,151,000USD-26,737,000USD-41,879,000USD-7,704,000USD
    Interest Income10,515,000USD16,345,000USD3,068,000USD2,150,000USD3,414,000USD819,000USD443,000USD—
    Interest Expense1,891,000USD1,886,000USD5,889,000USD7,547,000USD4,783,000USD3,579,000USD1,418,000USD980,000USD
    Net Interest Income8,624,000USD14,459,000USD-2,821,000USD-4,817,000USD-2,544,000USD-2,760,000USD-975,000USD—
    Income Before Tax-223,123,000USD-258,746,000USD-169,069,000USD-139,700,000USD-77,270,000USD-29,497,000USD-42,854,000USD-9,531,000USD
    Net Income-223,123,000USD-258,746,000USD-169,069,000USD-146,667,000USD-83,228,000USD-29,497,000USD-42,854,000USD-9,531,000USD
    Net Income From Continuing Ops-223,123,000USD-258,746,000USD-169,069,000USD-139,700,000USD-77,520,000USD-29,497,000USD-42,854,000USD-9,531,000USD
    Ebit-221,232,000USD-256,860,000USD-163,180,000USD-132,733,000USD-71,562,000USD-26,941,000USD-41,436,000USD-7,704,000USD
    Ebitda-210,207,000USD-247,485,000USD-157,807,000USD-131,588,000USD-71,136,000USD-26,737,000USD-41,267,000USD-7,704,000USD
    Depreciation And Amortization11,025,000USD9,375,000USD5,373,000USD1,145,000USD426,000USD204,000USD169,000USD—
    Reconciled Depreciation11,025,000USD9,375,000USD5,373,000USD1,145,000USD426,000USD200,000USD——
    Total Other Income Expense Net5,393,000USD14,459,000USD-1,821,000USD-3,697,000USD-1,119,000USD-2,760,000USD-975,000USD-847,000USD
    Income Tax Expense—-1USD516,000USD6,967,000USD5,958,000USD819,000USD443,000USD0USD
    Non Operating Income Net Other——156,000USD1,570,000USD4,589,000USD819,000USD443,000USD—
    Net Income Applicable To Common Shares——-169,069,000USD-139,700,000USD-77,270,000USD-29,497,000USD-42,854,000USD-9,531,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets285,407,000USD330,449,000USD368,033,000USD420,979,000USD471,066,000USD527,700,000USD393,688,000USD446,411,000USD
    Intangible Assets25,150,000USD25,150,000USD25,150,000USD25,150,000USD25,150,000USD25,150,000USD25,150,000USD25,150,000USD
    Other Current Assets5,448,000USD3,805,000USD4,922,000USD5,661,000USD6,329,000USD5,847,000USD6,092,000USD5,800,000USD
    Total Liab47,368,000USD53,228,000USD54,364,000USD66,768,000USD58,928,000USD64,466,000USD63,917,000USD61,776,000USD
    Total Stockholder Equity238,039,000USD277,221,000USD313,669,000USD354,211,000USD412,138,000USD463,234,000USD329,771,000USD384,635,000USD
    Other Current Liab17,319,000USD27,291,000USD25,585,000USD38,796,000USD29,490,000USD36,202,000USD34,363,000USD31,672,000USD
    Common Stock1,091,000USD1,083,000USD1,082,000USD1,079,000USD1,068,000USD1,065,000USD911,000USD910,000USD
    Capital Stock1,091,000USD1,083,000USD1,082,000USD1,079,000USD1,068,000USD1,065,000USD911,000USD910,000USD
    Retained Earnings-1,488,833,000USD-1,441,239,000USD-1,398,701,000USD-1,348,369,000USD-1,279,450,000USD-1,218,116,000USD-1,157,789,000USD-1,091,070,000USD
    Good Will39,154,000USD39,154,000USD39,154,000USD39,154,000USD39,154,000USD39,154,000USD39,154,000USD39,154,000USD
    Cash49,610,000USD77,558,000USD75,948,000USD32,819,000USD49,810,000USD163,635,000USD65,599,000USD38,607,000USD
    Cash And Short Term Investments144,379,000USD188,929,000USD222,758,000USD271,494,000USD318,164,000USD372,336,000USD235,662,000USD278,825,000USD
    Total Current Assets149,827,000USD192,734,000USD227,680,000USD277,155,000USD324,493,000USD378,183,000USD241,754,000USD292,725,000USD
    Total Current Liabilities24,466,000USD30,206,000USD31,170,000USD43,399,000USD35,311,000USD40,684,000USD39,980,000USD37,592,000USD
    Net Debt-24,846,000USD-52,681,000USD-50,903,000USD-7,617,000USD-24,458,000USD-138,137,000USD-39,957,000USD-12,809,000USD
    Short Term Debt2,924,000USD2,915,000USD2,912,000USD2,894,000USD2,876,000USD2,857,000USD2,847,000USD2,859,000USD
    Short Long Term Debt Total24,764,000USD24,877,000USD25,045,000USD25,202,000USD25,352,000USD25,498,000USD25,642,000USD25,798,000USD
    Short Term Investments94,769,000USD111,371,000USD146,810,000USD238,675,000USD268,354,000USD208,701,000USD170,063,000USD240,218,000USD
    Accounts Payable4,223,000USD—2,673,000USD1,709,000USD2,945,000USD1,625,000USD2,770,000USD3,061,000USD
    Property Plant Equipment Net69,453,000USD71,589,000USD74,169,000USD77,640,000USD80,393,000USD83,322,000USD85,765,000USD87,539,000USD
    Property Plant Equipment Gross100,184,000USD100,712,000USD101,614,000USD103,384,000USD104,097,000USD104,575,000USD105,196,000USD105,119,000USD
    Accumulated Other Comprehensive Income-112,000USD-31,000USD-9,000USD-107,000USD-27,000USD66,000USD213,000USD-218,000USD
    Common Stock Shares Outstanding112,134,059shares111,123,770shares111,571,136shares111,019,647shares110,093,461shares97,530,032shares94,158,491shares93,746,243shares
    Non Current Assets Total135,580,000USD137,715,000USD140,353,000USD143,824,000USD146,573,000USD149,517,000USD151,934,000USD153,686,000USD
    Non Current Liabilities Total22,902,000USD23,022,000USD23,193,999USD23,369,000USD23,617,000USD23,782,000USD23,937,000USD24,184,000USD
    Non Current Liabilities Other1,062,000USD1,060,000USD1,061,000USD1,061,000USD1,141,000USD1,141,000USD1,142,000USD1,245,000USD
    Non Currrent Assets Other482,000USD482,000USD515,000USD1,880,000USD1,876,000USD1,891,000USD503,000USD481,000USD
    Net Working Capital125,361,000USD162,528,000USD196,510,000USD233,756,000USD289,182,000USD337,499,000USD201,774,000USD255,133,000USD
    Unclassified Non Current Liabilities21,840,000USD21,962,000USD22,132,999USD22,308,000USD22,476,000USD22,641,000USD22,795,000USD22,939,000USD
    Unclassified Equity1,724,802,000USD1,716,325,000USD1,710,215,000USD1,700,529,000USD1,689,479,000USD1,679,154,000USD1,485,525,000USD1,474,103,000USD
    Long Term Investments—————0USD0USD0USD
    Other Assets———————1USD
    Net Receivables———————8,100,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets330,449,000USD527,700,000USD566,341,000USD551,807,000USD497,020,000USD590,824,000USD372,121,000USD251,313,000USD
    Intangible Assets25,150,000USD25,150,000USD25,150,000USD25,724,000USD——226,000USD—
    Other Current Assets3,805,000USD5,847,000USD5,047,000USD7,666,000USD3,319,000USD4,626,000USD3,639,000USD3,358,000USD
    Total Liab53,228,000USD64,466,000USD73,767,000USD62,121,000USD42,296,000USD87,305,000USD64,824,000USD57,276,000USD
    Total Stockholder Equity277,221,000USD463,234,000USD492,574,000USD489,686,000USD454,724,000USD503,519,000USD307,297,000USD194,037,000USD
    Other Current Liab27,291,000USD36,202,000USD45,789,000USD36,660,000USD19,615,000USD24,882,000USD15,833,000USD14,838,000USD
    Common Stock1,083,000USD1,065,000USD903,000USD791,000USD645,000USD610,000USD548,000USD452,000USD
    Capital Stock1,083,000USD1,065,000USD903,000USD791,000USD645,000USD610,000USD548,000USD452,000USD
    Retained Earnings-1,441,239,000USD-1,218,116,000USD-959,370,000USD-713,775,000USD-491,912,000USD-322,843,000USD-183,143,000USD-105,873,000USD
    Good Will39,154,000USD39,154,000USD39,154,000USD39,154,000USD30,815,000USD30,815,000USD30,815,000USD30,815,000USD
    Cash77,558,000USD163,635,000USD55,904,000USD140,517,000USD232,694,000USD297,098,000USD185,383,000USD111,355,000USD
    Cash And Short Term Investments188,929,000USD372,336,000USD373,175,000USD356,394,000USD388,740,000USD482,719,000USD304,115,000USD205,730,000USD
    Total Current Assets192,734,000USD378,183,000USD378,222,000USD364,060,000USD392,059,000USD487,345,000USD307,754,000USD209,088,000USD
    Total Current Liabilities30,206,000USD40,684,000USD48,505,000USD39,169,000USD22,167,000USD32,617,000USD18,309,000USD15,372,000USD
    Net Debt-52,681,000USD-138,137,000USD-30,862,000USD-117,651,000USD-210,093,000USD-235,401,000USD-137,934,000USD-69,908,000USD
    Short Term Debt2,915,000USD2,857,000USD2,716,000USD2,509,000USD2,552,000USD7,145,000USD1,914,000USD589USD
    Short Long Term Debt Total24,877,000USD25,498,000USD25,042,000USD22,866,000USD22,601,000USD61,697,000USD47,449,000USD41,447,589USD
    Short Term Investments111,371,000USD208,701,000USD317,271,000USD215,877,000USD156,046,000USD185,621,000USD118,732,000USD94,375,000USD
    Property Plant Equipment Net71,589,000USD83,322,000USD87,590,000USD77,645,000USD72,348,000USD70,641,000USD31,346,000USD2,027,000USD
    Property Plant Equipment Gross100,712,000USD104,575,000USD101,622,000USD86,738,000USD77,571,000USD70,641,000USD31,346,000USD2,027,000USD
    Accumulated Other Comprehensive Income-31,000USD66,000USD319,000USD-357,000USD-161,000USD-42,000USD20,000USD-127,000USD
    Common Stock Shares Outstanding111,123,770shares94,807,773shares84,009,004shares68,148,925shares63,235,417shares55,380,740shares49,010,358shares39,377,666shares
    Non Current Assets Total137,715,000USD149,517,000USD188,119,000USD187,747,000USD104,961,000USD103,479,000USD64,367,000USD42,225,000USD
    Non Current Liabilities Total23,022,000USD23,782,000USD25,262,000USD22,952,000USD20,129,000USD54,688,000USD46,515,000USD41,904,000USD
    Non Current Liabilities Other1,060,000USD1,141,000USD2,936,000USD2,595,000USD80,000USD19,622,000USD1,466,000USD—
    Non Currrent Assets Other482,000USD1,891,000USD1,905,000USD1,948,000USD1,798,000USD3,591,000USD1,980,000USD1,436,000USD
    Net Working Capital162,528,000USD337,499,000USD329,717,000USD324,891,000USD369,892,000USD454,728,000USD289,445,000USD193,716,000USD
    Unclassified Non Current Liabilities21,962,000USD22,641,000USD22,326,000USD17,762,000USD19,969,000USD———
    Unclassified Equity1,716,325,000USD1,679,154,000USD1,449,819,000USD1,202,236,000USD945,507,000USD825,184,000USD489,377,000USD299,801,000USD
    Long Term Investments—0USD34,320,000USD43,276,000USD0USD—0USD7,402,000USD
    Accounts Payable—1,625,000USD1,772USD36,660,000USD482USD835USD340USD589USD
    Current Deferred Revenue——-12,792,000USD-36,660,000USD-482USD590,000USD562,000USD534,000USD
    Other Liab———2,595,000USD80,000USD136,000USD23,000USD457,000USD
    Other Assets———1,948,000USD0USD0USD0USD1,981,000USD
    Net Tangible Assets———424,808,000USD454,843,000USD503,519,000USD307,297,000USD194,037,000USD
    Unclassified Non Current Assets———-1,948,000USD—-1,568,000USD—-1,436,000USD
    Unclassified Current Liabilities———-36,660,000USD—-4,875,835USD——
    Short Long Term Debt—————4,875,000USD——
    Long Term Debt—————35,066,000USD45,049,000USD41,447,000USD
    Treasury Stock——————-53,000USD-668,000USD
    Deferred Long Term Liab———————457,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-47,594,000USD-42,538,000USD-50,332,000USD-68,919,000USD-61,334,000USD-60,327,000USD-66,719,000USD-69,646,000USD
    Depreciation2,146,000USD2,217,000USD3,240,000USD2,579,000USD2,989,000USD2,361,000USD2,421,000USD2,371,000USD
    Stock Based Compensation8,493,000USD6,112,000USD9,759,000USD10,857,000USD10,331,000USD11,088,000USD11,248,000USD11,332,000USD
    Other Non Cash Items-1,020,000USD-826,000USD-1,599,000USD-2,212,000USD-2,075,000USD653,000USD699,000USD-2,242,000USD
    Change In Working Capital-7,419,000USD195,000USD-11,496,000USD8,731,000USD-5,713,000USD-732,000USD248,000USD4,333,000USD
    Total Cash From Operating Activities-45,394,000USD-34,840,000USD-50,428,000USD-48,964,000USD-55,802,000USD-46,957,000USD-52,103,000USD-53,852,000USD
    Capital Expenditures-93,000USD-80,000USD-54,000USD-50,000USD-364,000USD-309,000USD-1,588,000USD-1,930,000USD
    Free Cash Flow-45,487,000USD-34,920,000USD-50,374,000USD-49,014,000USD-56,166,000USD-47,266,000USD-53,691,000USD-55,782,000USD
    Investments17,541,000USD36,505,000USD93,616,000USD31,761,000USD-58,035,000USD-37,871,000USD78,919,000USD55,624,000USD
    Total Cashflows From Investing Activities17,448,000USD36,425,000USD93,616,000USD31,761,000USD-58,035,000USD-37,871,000USD78,919,000USD55,624,000USD
    Net Borrowings-1,000USD———0USD———
    Total Cash From Financing Activities-1,000USD2,000USD-59,000USD215,000USD12,000USD182,864,000USD176,000USD1,559,000USD
    Change In Cash-27,947,000USD1,585,000USD43,129,000USD-16,988,000USD-113,825,000USD98,036,000USD26,992,000USD3,331,000USD
    Begin Period Cash Flow78,898,000USD77,313,000USD32,819,000USD51,172,000USD163,635,000USD65,599,000USD39,969,000USD35,276,000USD
    End Period Cash Flow50,951,000USD78,898,000USD75,948,000USD34,184,000USD49,810,000USD163,635,000USD66,961,000USD38,607,000USD
    Other Cashflows From Financing Activities-1,000USD12,000USD-67,000USD-13,000USD—56,000USD-24,000USD55,624,000USD
    Sale Purchase Of Stock—0USD——————
    Issuance Of Capital Stock—0USD-215,000USD215,000USD0USD182,849,000USD176,000USD1,530,000USD
    Unclassified Investing Cash Flow——————1,588,000USD1,930,000USD
    Unclassified Financing Cash Flow———————-55,595,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Net Income-223,123,000USD-258,746,000USD-245,595,000USD-221,863,000USD-169,069,000USD-74,518,000USD-29,497,000USD-42,854,000USD
    Depreciation11,025,000USD9,375,000USD7,098,000USD6,266,000USD5,373,000USD330,000USD200,000USD169,000USD
    Stock Based Compensation37,059,000USD43,920,000USD39,406,000USD31,009,000USD29,237,000USD13,601,000USD4,036,000USD2,909,000USD
    Other Non Cash Items-6,677,000USD-6,192,000USD-9,283,000USD370,000USD13,534,000USD2,898,000USD522,000USD162,000USD
    Change In Working Capital-8,298,000USD1,919,000USD13,458,000USD6,076,000USD-3,386,000USD4,385,000USD-2,027,000USD2,123,000USD
    Total Cash From Operating Activities-190,014,000USD-209,724,000USD-194,916,000USD-178,142,000USD-121,163,000USD-53,788,000USD-26,112,000USD-37,266,000USD
    Capital Expenditures-440,000USD-5,862,000USD-16,472,000USD-8,619,000USD-7,715,000USD-1,453,000USD-70,000USD-487,000USD
    Free Cash Flow-190,454,000USD-215,586,000USD-211,388,000USD-186,761,000USD-128,878,000USD-55,241,000USD-26,182,000USD-37,753,000USD
    Investments104,207,000USD131,706,000USD-65,846,000USD-69,326,000USD26,568,000USD-79,811,000USD75,085,000USD-65,572,000USD
    Total Cashflows From Investing Activities103,767,000USD131,706,000USD-98,066,000USD-69,326,000USD18,853,000USD-5,272,000USD75,015,000USD-66,059,000USD
    Total Cash From Financing Activities148,000USD185,739,000USD208,401,000USD155,288,000USD37,681,000USD153,502,000USD25,406USD16USD
    Sale Purchase Of Stock-67,000USD0USD0USD-47,000USD37,681,000USD-668,000USD35,000USD155,000USD
    Issuance Of Capital Stock0USD185,739,000USD315,859,000USD154,704,000USD26,354,000USD154,022,000USD——
    Change In Cash-86,099,000USD107,721,000USD-84,581,000USD-92,180,000USD-64,629,000USD94,442,000USD48,922,000USD-50,244,000USD
    Begin Period Cash Flow164,997,000USD57,276,000USD141,857,000USD234,037,000USD298,666,000USD18,349,000USD29,798,000USD80,042,000USD
    End Period Cash Flow78,898,000USD164,997,000USD57,276,000USD141,857,000USD234,037,000USD112,791,000USD78,720,000USD29,798,000USD
    Other Cashflows From Financing Activities215,000USD-95,000USD-132,000USD-172,000USD-201,000USD148,000USD19,000USD346,000USD
    Other Cashflows From Investing Activities—131,706,000USD—-103,694USD-95,000USD-356,000USD-376,000USD-376,000USD
    Unclassified Investing Cash Flow—-125,844,000USD-15,748,000USD8,722,694USD—76,348,000USD——
    Unclassified Financing Cash Flow—185,834,000USD208,533,000USD155,679,000USD—154,022,000USD—-49,083,984USD
    Change To Liabilities———9,674,000USD-4,827,000USD5,890,000USD-2,987,000USD3,071,000USD
    Dividends Paid———-172,000USD——0USD-155,000USD
    Cash And Cash Equivalents Changes————-64,629,000USD94,442,000USD48,922,000USD-50,244,000USD
    Unclassified Operating Cash Flow————3,148,000USD———
    Change To Account Receivables——————0USD0USD
    Change To Inventory——————0USD0USD
    Net Borrowings———————48,738,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.